Home › Kanser sa Dugo › Alabama › Birmingham

Pag-aaral pangklinika para sa Kanser sa Dugo sa Birmingham, AL

Isang pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Birmingham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 2

University of Alabama Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04634552

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Nagre-recruitPhase 3

Quetzal Site 16, Birmingham

Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2

O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

University of Alabama at Birmingham, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Nagre-recruitPhase 3

Children's Hospital of Alabama, Birmingham

Edad 2 hanggang 18 · Lahat ng kasarian · Na-update May 5, 2026 · NCT05711667

Cognitive Training Intervention and Attitudes Towards Genetics

Nagre-recruit

University of Alabama at Birmingham, Birmingham

Edad 21 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT03094026

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

Nagre-recruitPhase 1

University of Alabama at Birmingham, Birmingham

4 Weeks – 75 Years · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06047886

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Nagre-recruitPhase 1

University of Alabama at Birmingham, Birmingham

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT07044544

Diet and Cognitive Training in Hematologic Cancer Survivors

Nagre-recruit

University of Alabama at Birmingham, Birmingham

Edad 21 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT05708716

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Nagre-recruit

University of Alabama at Brimingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2025 · NCT06472089

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Nagre-recruitPhase 1

University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Pag-aaral para sa Kanser sa Dugo sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.